Craig Eagle reports a stock award at OS Therapies

By AlphaYouPublished Oct 31, 2026Form 4

Stocks in this disclosure

Reported activity

EAGLE CRAIG

Reporting filer

Craig Eagle reports a stock award, not an open-market purchase or sale, in OS Therapies Inc. Form 4 filed Oct 31, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock options (right to buy) (derivative)	EAGLE CRAIG	2026-10-22	A	Grant or award	300000	0	300,000	9 days	Filed terms security Title: Stock options (right to buy) conversion Or Exercise Price: 1.25 transaction Date: 2026-10-22 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 300000 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-10-22 underlying Security Title: Common Stock underlying Security Shares: 300000 shares Owned Following Transaction: 300000 direct Or Indirect Ownership: D

Owner: EAGLE CRAIG
Date: 2026-10-22
Code: A
Action: Grant or award
Quantity: 300000
Price: 0
Following holdings: 300,000
Reporting delay: 9 days
Filed terms and references: Filed terms
security Title: Stock options (right to buy)
conversion Or Exercise Price: 1.25
transaction Date: 2026-10-22
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 300000
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-10-22
underlying Security Title: Common Stock
underlying Security Shares: 300000
shares Owned Following Transaction: 300000
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
EAGLE CRAIG: Director.
F1: On October 22, 2026, the reporting person was granted options to purchase 300,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement and the issuer's amended and restated 2023 incentive compensation plan. These options vest in 12 equal installments on each monthly anniversary of the date of grant, provided that the reporting person is serving as a director of the issuer on each applicable vesting date.

Prepared automatically from public filing data. Report a correction.